for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bayer AG

BAYGn.DE

Latest Trade

74.68EUR

Change

-1.07(-1.41%)

Volume

2,196,629

Today's Range

74.58

 - 

75.98

52 Week Range

52.02

 - 

76.11

As of on the XETRA ∙ Minimum 15 minute delay

Pricing

Previous Close
75.75
Open
75.88
Volume
2,196,629
3M AVG Volume
50.67
Today's High
75.98
Today's Low
74.58
52 Week High
76.11
52 Week Low
52.02
Shares Out (MIL)
982.42
Market Cap (MIL)
74,173.02
Forward P/E
11.84
Dividend (Yield %)
3.71

Next Event

Bayer AG Crop Science R&D Pipeline Update

Latest Developments

More

WuXi Biologics Germany To Take Over Bayer's Leverkusen Drug Product Plant

Wuxi Biologics Cayman Announces Acquisition Of Facility Assets Of A Biologics Drug Product

Bayer Signs License Agreement With Daré Bioscience For U.S. Commercial Rights To Ovaprene

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Bayer AG

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.

Industry

Major Drugs

Contact Info

Kaiser-Wilhelm-Allee 1

+49.214.301

https://www.bayer.de/

Executive Leadership

Werner Wenning

Independent Chairman of the Supervisory Board

Werner Baumann

Chairman of the Management Board, Chief Executive Officer

Oliver Zuehlke

Independent Vice Chairman of the Supervisory Board, Employee Representative

Wolfgang U. Nickl

Chief Financial Officer, Member of the Management Board

Liam Condon

Member of the Management Board, Head of the Crop Science Division, Animal Health Business Unit

Key Stats

2.29 mean rating - 28 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2016

46.8K

2017

35.0K

2018

39.6K

2019(E)

43.9K
EPS (EUR)

2016

7.204

2017

6.633

2018

5.940

2019(E)

6.375
Price To Earnings (TTM)
--
Price To Sales (TTM)
1.69
Price To Book (MRQ)
1.53
Price To Cash Flow (TTM)
20.71
Total Debt To Equity (MRQ)
95.26
LT Debt To Equity (MRQ)
82.15
Return on Investment (TTM)
-1.39
Return on Equity (TTM)
-1.14

Latest News

Latest News

Bayer could be close to Roundup settlement, mediator says

Bayer could be close to settling more than 75,000 cancer claims related to its Roundup herbicide, with mediator Ken Feinberg on Friday saying he was "cautiously optimistic that a settlement will ultimately be reached."

Bayer close to Roundup settlement, mediator tells Bloomberg

Bayer is close to settling more than 75,000 cancer claims related to its Roundup herbicide, mediator Ken Feinberg told Bloomberg in an interview, saying he was "cautiously optimistic" a deal could be reached in about a month.

German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

Germany's drug assessment body said that data provided by Bayer on its precision cancer drug Vitrakvi did not provide clear enough evidence of benefits, in a setback to the drugmaker in its home market.

EU Commission bans Bayer pesticide linked to harming bees

(This January 13 story was refiled to clarify EU's staggered deadline, paragraphs 4-5)

EU Commission bans Bayer pesticide linked to harming bees

The European Commission decided on Monday not to renew approval for a pesticide linked to harming bees, effectively banning Bayer's insecticide known as thiacloprid.

Bayer shares up 3.5% after U.S. government's backing in glyphosate lawsuit

Bayer <BAYGn.DE> shares rose as much as 3.5% on Monday, reaching their highest level in 14 months, after the United States government said that a $25 million (19 million pounds) glyphosate decision against the company should be reversed.

U.S. government says verdict in Bayer's Roundup case should be reversed

The U.S. Environmental Protection Agency and the Justice Department said a federal appeals court should reverse a lower court verdict finding Bayer AG liable in the case of a California man who blamed its Roundup weed killer for his cancer.

Bayer asks U.S. appeals court to reverse $25 million Roundup verdict

Bayer AG on Monday said it has asked a U.S. federal appeals court to throw out a $25 million judgment it was ordered to pay to a California man who blamed the company's Roundup weed killer for his cancer.

BRIEF-Crispr Therapeutics - On Dec. 13, 2019, Crispr, Bayer, Casebia Entered Into Retirement Agreement

* CRISPR THERAPEUTICS - ON DEC. 13, 2019, CRISPR, BAYER, CASEBIA ENTERED INTO RETIREMENT AGREEMENT

Bayer reaches agreement to postpone more glyphosate lawsuits for settlement talks

Germany's Bayer <BAYGn.DE> has agreed with plaintiffs to postpone its next two U.S. lawsuits over the alleged cancer-causing effects of its glyphosate-based weed killers to allow more time for talks on a settlement.

UPDATE 6-Bundesliga Summaries

Summaries for the Bundesliga on Saturday (start times are CET) Bayer Leverkusen (1) 1 Scorers: M. Diaby 36 Subs used: Bender 26 (Weiser), Alario 74 (Volland), Paulinho 89 (Amiri) Freiburg (1) 1 Scorers: L. Höler 5 Yellow card: Lienhart 46, Schmid 59, Höfler 65 Subs used:...

Bayer's Monsanto pleads guilty to illegal Hawaii pesticide spraying

Monsanto pleaded guilty to spraying a banned pesticide on the Hawaiian island of Maui, and agreed to pay $10.2 million in criminal fines and other payments for the spraying and for illegally storing hazardous waste, U.S. prosecutors said.

Roche says Tecentriq cocktail helps liver cancer patients live longer

Swiss drugmaker Roche on Friday said its immunotherapy Tecentriq combined with its Avastin medicine helped people with the most common form of liver cancer to live longer than with an older drug from Germany's Bayer.

Merck and Bayer's heart drug meets main goal of late-stage study

Merck & Co Inc <MRK.N said on Monday an experimental treatment being developed with Bayer AG for patients with worsening chronic heart failure met the main goal of a late-stage study.

Merck and Bayer's heart drug meets main goal of late-stage study

Merck & Co Inc <MRK.N said on Monday an experimental treatment being developed with Bayer AG for patients with worsening chronic heart failure met the main goal of a late-stage study. The drug, vericiguat, reduced the risk of heart failure and hospitalization in patients...

Mediation between Bayer, plaintiffs seeks to clarify all justified claims: U.S. mediator

Mediation between Bayer and plaintiffs in the United States aims to clarify all justified claims related to Roundup herbicide both at the national and state level, mediator Ken Feinberg told a German magazine.

Bundesliga Top Scorers

Top Scorers in the Bundesliga on Friday 1 R. Lewandowski (Bayern München) 14 2 T. Werner (Leipzig) 9 3 R. Hennings (Düsseldorfer TuS Fortuna 1895) 6 Gonçalo Paciência (Eintracht Frankfurt) 4 Paco Alcácer (Borussia Dortmund) 5 A. Harit (Schalke 04) N. Petersen (Freiburg)...

UPDATE 2-Bundesliga Top Scorers

Top Scorers in the Bundesliga on Sunday 1 R. Lewandowski (Bayern München) 14 2 T. Werner (Leipzig) 9 3 R. Hennings (Düsseldorfer TuS Fortuna 1895) 6 Gonçalo Paciência (Eintracht Frankfurt) 4 Paco Alcácer (Borussia Dortmund) 5 A. Harit (Schalke 04) N. Petersen (Freiburg)...

Bundesliga Top Scorers

Top Scorers in the Bundesliga on Saturday 1 R. Lewandowski (Bayern München) 14 2 T. Werner (Leipzig) 9 3 Gonçalo Paciência (Eintracht Frankfurt) 6 4 Paco Alcácer (Borussia Dortmund) 5 R. Hennings (Düsseldorfer TuS Fortuna 1895) N. Petersen (Freiburg) M. Reus (Borussia Dortmund...

Bayer says U.S. glyphosate plaintiffs more than double since July

Germany's Bayer is now facing 42,700 U.S. plaintiffs blaming its glyphosate-based weedkillers for their cancer, more than twice the tally in July and potentially raising any future settlement.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up